Clinical Trial: Differing Levels of Positive Anti-Neutrophil Cytoplasm Antibody (ANCA) Test and Their Correlation With Vasculitis or Malignancy or Chronic Inflammation

Study Status: Recruiting
Recruit Status: Unknown status
Study Type: Observational

Official Title:

Brief Summary: A positive Anti-Neutrophil Cytoplasm Antibody (ANCA) test administered to patients with a high probability for vasculitis has high sensitivity and specificity for vasculitis. A positive ANCA test result in those patients who do not have a high probability for vasculitis requires extensive follow-up because those patients eventually present with malignancy or other inflammatory diseases. The investigators wish to investigate the correlation between the differing levels of positive ANCA tests and their relationship to vasculitis, malignancy and inflammatory diseases.

Detailed Summary:
Sponsor: Hillel Yaffe Medical Center

Current Primary Outcome: Borderline Positive ANCA [ Time Frame: Two weeks ]

Borderline positive ANCA results of 12-19 U/ml is indication of possible malignancy or inflammatory diseases


Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Hillel Yaffe Medical Center

Dates:
Date Received: July 1, 2014
Date Started: August 2014
Date Completion: January 2015
Last Updated: July 1, 2014
Last Verified: July 2014